# name
Future prospects for Antimicrobial peptide development: peptidomimetics and antimicrobial combinations

# metadata.dc.description.abstract[].value
Antimicrobial resistance is widely recognized as one of the major challenges of public health worldwide, as infections by multidrug-resistant (MDR) bacteria have reached worrisome levels. Three levels of antibiotic resistance have been described [Citation1]: i) multi-resistance (resistance to at least three different families of antimicrobials), ii) extreme resistance (resistance to all antimicrobials except colistin) and iii) pan-drug resistance (resistance to all available antimicrobials).

# metadata.dc.relation.ispartof[].value
Expert Opinion on Drug Discovery, 2021, vol. 16, num.6, p. 601-604

# metadata.dc.source[].value
Articles publicats en revistes (Patologia i Terapèutica Experimental)

# metadata.dc.title[].value
Future prospects for Antimicrobial peptide development: peptidomimetics and antimicrobial combinations